Mallinckrodt Plc (MNKKQ) Return on Equity ROE from the second quarter 2026 to second quarter 2022 and annually, average high and low, overall ranking from Jun 30 2026 to Apr 01 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mallinckrodt Plc  (MNKKQ)

Mallinckrodt Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Mallinckrodt Plc in the second quarter 2026?
Mallinckrodt Plc achieved a return on average equity (ROE) of 15.36 % in its second quarter 2026, this is above MNKKQ's average return on equity of -34.07%.
Mallinckrodt Plc shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $1,310 million

ROE decreased relative to the period ending , due to the decline in net income.

Within the Major Pharmaceutical Preparations industry 445 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2025 from 4208 to 4422.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Jun 27 2025)
II. Quarter		 (Dec 27 2024)
IV. Quarter		 (Jun 16 2022)
II. Quarter		 (Apr 01 2022)
I. Quarter
Y / Y Equity Change 460.56 % 219.81 % 112.09 % -77.81 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 201 302 96 -781 -693
Return On Equity (TTM) 15.36 % 31.83 % 14.35 % -173.72 % -111.71 %
MNKKQ's Total Ranking # 4422 # 4208 # # #
Equity (TTM) in Millions 1,757 1,642 1,646 195 313
Seq. Equity Change 7 % -0.24 % 744 % -37.78 % -38.96 %
Seq. Net Income Change - -99.61 % - - -

Back to MNKKQ Management Effectiveness >> MNKKQ's 5 Years Annual ROE >> Compare MNKKQ ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 446
Sector # 903
Overall # 4422

Return On Equity Statistics
High Average Low
39.08 %
-34.07 %
-173.72 %
(Dec 29 2017)   (Jun 16 2022)





MNKKQ Annual Return On Equity (Dec 27 2024)
2024		 (Dec 31 2021)
2021		 (Dec 25 2020)
2020		 (Dec 27 2019)
2019		 (Dec 28 2018)
2018
Total Equity in Millions 1,646 313 1,019 1,941 2,887
Y / Y Equity Change 425.14 % -69.25 % -47.48 % -32.78 % -55.73 %
Net Income in Millions 478 -717 -945 -997 -3,607
Y / Y Net Income Change - - - - -
Return On Equity 29.04 % -228.91 % -92.68 % -51.35 % -124.93 %

Back to MNKKQ Management Effectiveness >> MNKKQ's 5 Years Annual ROE >> Compare MNKKQ ROE to its Competitors




Annual Roe Comment
In 2024 ROE improved to 29.04 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MNKKQ's' Return on Equity at Yahoo Finance
MNKKQ's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MNKKQ's Competitors
Subscribers only: Roe for Mallinckrodt Plc's Suppliers
Subscribers only: Return On Equity for MNKKQ's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %
Caredx Inc   32.81 %
Zevra Therapeutics Inc   32.56 %
Acadia Pharmaceuticals Inc   32.39 %
Pro dex Inc   31.96 %
Protalix Biotherapeutics inc   31.61 %
Illumina Inc   31.08 %
Innoviva Inc   30.03 %
Phibro Animal Health Corporation  29.66 %
Chemed Corporation  29.45 %
Solventum Corporation  28.96 %
Pacs Group Inc   27.00 %
Sotera Health Company  26.75 %
Insulet Corporation  26.69 %
Bioventus Inc   25.96 %
Johnson and Johnson  25.74 %
Encompass Health Corporation  25.52 %
Resmed Inc   24.21 %
Healthcare Services Group Inc   24.12 %
Electromed Inc   23.65 %
Iradimed Corporation  23.45 %
Vertex Pharmaceuticals Inc  23.31 %
Lantheus Holdings Inc   23.27 %
Msa Safety Inc  23.15 %
Prestige Consumer Healthcare Inc   21.77 %

Date modified: 2026-09-26T06:54:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.